Its another day, and so it's time to look at another gold miner - today it is Evolution Mining's (ASX:EVN) turn in the spotlight. As of mid-June 2025 it is the 2nd largest gold miner behind Northern Star (ASX:NST) and the 35th largest company on the ASX, newly added to the ASX 50 in the…
Large Caps
In the decade since fertility provider Monash IVF (ASX:MVF) listed, it was not an easy journey. Only a few months ago, we thought the business had turned a corner and many others did too. Then...trouble struck. Is this a buy the dip opportunity, or a risk of catching a falling knife?
Introduction to Monash IVF
Monash…
Addressing the ASX decline is a question that has been considered for many months now. In 2023-24, more companies left the ASX in the past 2 years than any 2 year period since the 1990s recession - whether being brought out by private equity or a big industry player, delisting to a penny stock exchange…
Investors have just heard about TopCo, a company being born from $14bn merger of Brickworks (ASX:BKW) and Washington H. Soul Pattinson (ASX:SOL). For now the combined ASX company will be called TopCo but will eventually adopt the latter's name.
A combination of the two seemed inevitable for many years, given their close affiliation - the former is…
Investors asking themselves, 'Should I buy Apple shares from Australia,' are not just considering buying shares any company, but the world's largest. Capped at over $3tn, the Silicon Valley-based tech (and arguably luxury) company has risen to spectacular new heights since the departure and death of Steve Jobs, surpassing $1tn in August 2018, $2tn in…
Will Ozempic hurt healthcare stocks? Investors who've been selling healthcare stocks left right and centre - except Novo Nordisk of course, now the largest stock in Europe by market capitalisation - believe it will. But even though we hear these arguments loud and clear, we think these fears are overblown.
Ozempic is a weight-loss drug that…
Ventia Services (ASX:VNT) listed on the ASX in November 2021 at $1.5bn and is now capitalised at $4bn. Since listing it has recorded persistent revenue and profit growth. There is very little to complain about from a financial perspective, and it may still be undervalued. However, things aren't completely perfect for it.
Overview of Ventia…
Have some sympathy for Nufarm (ASX:NUF). Companies capped at over $1bn rarely plunge 30% after reporting results unless the results (or the outlook) were bad enough to warrant it, and this is just what happened earlier this week.
Introduction to Nufarm (ASX:NUF)
Nufarm is an agricultural chemical supplier and manufacturer - its most important is omega-3…
'The investor who says, "This time is different," when in fact it’s virtually a repeat of an earlier situation, has uttered among the four most costly words in the annals of investing'. This quote was said by John Templeton’s in his work '16 rules for Investment Success'.
Why Templeton thought 'This Time is Different' was…
After many decades at the helm of Berkshire Hathaway, Warren Buffett is retiring. After founding his empire in 1965, he built it into a US$1tn+ empire owning many of America's best companies and profiting off them. But of course, all good things must come to an end - at least a tenure led by the…
